Search Thermo Fisher Scientific
A suggested positive control is SW480 cell lysate.
PA5-34436 can be used with blocking peptide PEP-1478.
The Epilepsy, progressive myoclonus type 2A protein (EPM2A) is a dual-specificity phosphatase that associates with polyribosomes. Mutations in this gene have been associated with myoclonic epilepsy of Lafora. EPM2A interacts with a number of proteins known to be involved in glycogen metabolism and has been shown to have robust phosphatase activity against a phosphorylated complex carbohydrate, suggesting that EPM2A may be involved in the regulation of glycogen metabolism.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: epilepsy, progressive myoclonic epilepsy, type 2 gene alpha; epilepsy, progressive myoclonus type 2, Lafora disease (laforin); EPM2A; Glucan phosphatase; Glycogen phosphatase; Lafora PTPase; Laforin; LAFPTPase; RP1-28C20.2
基因别名: EPM2; EPM2A; MELF; Tg(TcraK,TcrbK)TG-BFlv; TG-B
UniProt ID: (Human) O95278, (Rat) Q91XQ2, (Mouse) Q9WUA5
Entrez Gene ID: (Human) 7957, (Rat) 114005, (Mouse) 13853